Test composition for the determination of triglycerides and its use.
Abstract
Triglycerides in a sample are quantitatively determined using a test composition having a system for converting the triglycerides to fatty acids and glycerol, a system for oxidizing the glycerol, and a system for determining the amount of oxygen consumed or the amount of hydrogen peroxide or glyceraldehyde formed in the oxidation of the glycerol.

Term
Term ended
Projected expiry passed 17 October 1999, 26.9 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
5 claims: 3 independent, 2 dependent
- 1A test composition for the determination of triglycerides in a sample which comprises:a system for converting triglycerides in said sample to acids and glycerol;a system for oxidizing the glycerol with glycerol oxidase in the presence of oxygen to form glyceraldehyde and hydrogen peroxide;and a system for determining the amount of glyceraldehyde or hydrogen peroxide formed or the amount of oxygen consumed.
- 4A test composition for the determination of triglycerides in a sample which comprises an enzyme system selected from the group consisting of lipoprotein lipase, cholesterol esterase and lipase and protease;glycerol oxidase;peroxidase;and a coloring reagent selected from the group consisting of phenol and 4-aminoantipirine, dimethylaniline and 4-aminoantipirine, 3-methyl-2-benzothiazolinone hydrazone and O-toluidine, 3-methyl-2-benzothiazolinone and N,N-dimethylaniline, O-dianicidine, and 4-aminoantipirine and N-ethyl-N-(3-methylphenyl)-N'-acetylethylenediamine.
Independent claims3
60 paragraphs, as filed
Background of the Invention
0001The present invention relates to a method for the quantitative determination of triglycerides in a sample by an enzymatic reaction and a test composition suitable therefor.
0002The determination of triglycerides is a clinically significant lipid test for hyper-lipoidemia. However, the conventional methods for such determination are burdensome in operation and are, therefore, inconvenient for routine use.
0003For example, the most commonly employed procedure at present is the acetylacetone test in which triglycerides are first isolated by extraction with an organic solvent. The triglycerides are then hydrolyzed with an alkali and the glycerol which is formed is oxidized with an oxidizing agent such as sodium metaperio- date. The formaldehyde thus formed is condensed with acetylacetone and the degree of the color developed is determined by colorimetry. The operation thus comprises several steps. The acetylacetone procedure is disclosed in, for example, M.J. Fletcher, "A colorimetric method for estimating serum triglycerides" Clinica Chimica Acta Vol. 22, 393-397 (1968).
0004More recently, a method for the determination of serum triglycerides by an enzymatic reaction is disclosed in U.S. Patent No. 4,038,146. In this method, triglycerides are hydrolyzed into fatty acids and glycerol by the action of lipoprotein lipase and the glycerol is converted to dihydroxyacetoneeby- the action of glycerol dehydrogenase in the presence of nicotinamide adenine dinucleotide (NAD). The NADH thus formed is converted to a pigment and the degree of color development in the visible ray region is measured. Although this method is capable of being carried out in one step, it is difficult to adapt to automatic analytical instruments.
0005It has now been found that triglycerides in a sample may be quantitatively determined simply by the hydrolysis of triglycerides, the enzymatic oxidation of products glycerol thus produced and thereafter detecting the / so formed or alternatively the consumption of oxygen.
Summary of the Invention
0006According to the present invention, triglycerides in a sample are quantitatively determined by solvolysis of the triglycerides to form fatty acids and glycerol, oxidizing the glycerol with glycerol oxidase in the presence of oxygen to form glyceraldehyde and hydrogen peroxide and determining the amount of glyceraldehyde or hydrogen peroxide formed or determining the oxygen uptake. Broadly, the mechanism of the present invention is illustrated as follows: <chemistry id="chem0001" num="0001"><img file="EP0010296A1_D0001.tif" /></chemistry>
0007The reactions described above proceed stoichiometrically and the amount of glyceraldehyde or hydrogen peroxide formed or oxygen uptake is proportional to the amount of triglyceride in the test sample.
Detailed Description of the invention
0008Basically, the method and test composition for the determination of the present invention comprises a system for converting triglycerides in a sample to glycerol and fatty acids (System I), a system for oxidizing the glycerol with glycerol oxidase in the presence of oxygen to form glyceraldehyde and hydrogen peroxide (System II) and a system for determining the glyceraldehyde or hydrogen peroxide formed or oxygen uptake (System III).
0009System I is carried out by applying conventional methods such as by solvolysis using an enzyme or an alkali. Typical enzymes include lipoprotein lipase (hereinafter referred to as LPL), cholesterol esterase, lipase and protease, or the like.
0010Glycerol oxidase (hereinafter referred to as GOD) used in the enzymatic conversion (System II) is op- tained from cell bodies of a microorganism belonging to the genus Aspergillus, Neuros<sup>p</sup>ora or Penicillium by extraction and purification as is disclosed in the present inventors' commonly owned German Offenlegungs- schrift 2 817 087 filed April 19, 1978 and commonly owned West German Patent Application P 29 29 530, filed July 20, 1979. For ease of reference, typical methods thereof are hereinafter described in examples 1 and 2 Other GOD may be used if it catalizes the above reaction.
0011The determination of the hydrogen peroxide formed may be carried out according to conventional methods. Methods using peroxidase (hereinafter referred to as POD) or catalase are particularly suitable because the determination is carried out in one step.
0012In the method using peroxidase, hydrogen peroxide is reacted with a coloring reagent to form a pigment and the absorption of the reaction solution is measurad at the visible ray region, i.e. 400 - 600 nm. Suitable coloring reagents for the determination of hydrogen peroxide using peroxidase are selected from 4-aminoantipirine (hereinafter referred to as 4-AA) and phenol, 4-AA and dimethylaniline, 3-methyl-2-benzothiazolinone hydrazone (hereinafter referred to as MBTH) and O-toluidine, MBTH and N,N-dimethylaniline, 0-dianicidine, 4-AA and N-ethyl-N-(3-methylphenyl)-N'- acetylethylenediamine, and the like.
0013In the method using catalase, hydrogen peroxide is reacted with methanol in the presence of catalase to form formaldehyde which is then reacted with acetylacetone in the presence of ammonia to form a yellow pigment, i.e., 3,5-diacetyl-1,4-dihydrolutidine, and the absorption of the reaction solution is measured colorimetrically.
0014In the determination of the glyceraldehyde formed, the glyceraldehyde is reacted with 2,4-dinitrophenylhydrazine in the presence of a strong alkali to form a colored substance, i.e. 2,4-dinitrophenylhydrazone and the absorption of the reaction solution is measured at 495 nm. In this method, the pH of the enzymatic reaction and the pH of the coloring reaction system are different and therefore, the determination cannot be carried out in one step.
0015In the determination of oxygen uptake, a sample containing triglycerides, a reagent for saponification of triglyceride and glycerol oxidase are dissolved in a buffer solution and the partial pressure of oxygen is measured by suitable known means.
0016In the determination of triglycerides in serum, when the serum contains triglycerides in high concentration and is turbid, the turbidity may be decreased by the addition of a surfactant in an amount of 0.1% such as Triton X 100 (iso-octylphenoxy-poly-ethoxy ethanol containing ethylene oxide, product sold by Wako Junyaku Co., Ltd. and Rohm & haas Co.) or Brij® 35 (polyoxyethylene- laurylether, Atlas Chemical Industries, Inc. and Wako Junyaku Co., Ltd.).
0017According to the present invention, the determination of triglycerides may be performed by conducting the individual systems stepwise and may preferably be performed by subjecting the sample to enzymatic reaction with a reagent comprising an enzyme for converting triglyceride to glycerol, GOD and POD or catalase.
0018The enzymatic reactions in the present invention are carried out at 20 - 45°C, preferably 30 - 40°C and at pH 5 - 10 for 4 - 30 minutes.
0019The enzyme reagent of the present invention is preferably prepared by dissolving the enzyme(s) necessary for the determination in a buffer solution and freeze-drying the solution. The buffer solution is not limited except that the solution should exhibit the buffer action in the range of pH 6.0 - 9.5, and a preferred buffer solution is a 0.1M N-Tris (hydroxymethyl) methyl-2-aminoethane sulfonic acid (hereinafter referred . to as TES) buffer solution (pH 8.0).
0020In the following Examples 1 and 2, production of GOD is illustrated.
Example 1
0021In this example, Aspergillus japonicus KY-45 (ATCC 1042, NRRL 11102, FERM-P No. 3959) is inoculated in 300 ml of seed medium containing 10 g/l of glycerol, 10 g/1 of malt extract, and 5 g/1 of yeast extract (pH 6.2 before sterilization) in a` 2 ℓ Erlenmeyer flask, and cultured at 30°C with shaking for 48 hours. Nine hundred milliliters (corresponding to three flasks) of the resulting seed culture is inoculated in 15 ℓ of the same medium as the seed medium in a 30 ℓ jar fermenter, and cultured at 30°C with aeration (15 ℓ/min.) and stirring (250 rpm) for 40 hours. The resulting culture broth is then filtered through a Buchner funnel, and the cakes are washed with water, whereby about 150 g (dry basis) of microbial cells is obtained.
0022The microbial cells are suspended in 5 ℓ of 10 mM ammonium buffer solution (pH B.), and disrupted in a Dyno-mill (made by Willy A. Bachofen, Switzerland). After disruption, the suspension is centrifuged with a freezing centrifuge (20,000 x G for 20 minutes), and 4.7 1 of the supernatant (protein content: 51 g, specific activity: 0.05 units/mg) is obtained. The resulting supernatant is then admixed with ammonium sulfate, and fractions precipitated at 30 - 70% saturation with ammonium sulfate are collected and dissolved in 50 ml of a 10 mM ammonium buffer solution (pH 8.0). The resulting solution is dialyzed against 10 ℓ of the 10 mM ammonium buffer solution, using a cellophane tube as a dialysis membrane.
0023Dialysis is continued for 48 hours with a total of 40 A of the dialysis solution, while exchanging the dialysis solution every 12 hours. Dialyzed enzyme solution is passed through a column (5.5 x 40 cm) of <sub>D</sub>EAE cellulose (made by Serva Co., West Germany) equilibrated in advance with 10 mM ammonium buffer solution (pH 8.0). The enzyme is adsorbed by this operation, and unadsorbed impure protein is washed out with the same buffer. Then, elution is carried out with a linear gradient of 0.1M to 0.2M ammonium sulfate in 2 ℓ of 10 mM ammonium buffer solution (pH 8.0), whereby glycerol oxidase is eluted. Five hundred milliliters of the active fractions (protein content: 1.2 g, specific activity 1.1) are collected, and admixed with ammonium sulfate to 70% saturation to precipitate the enzyme.
0024tolowna. The precipitates are collected by centrifugation (20,000 x G for 20 minutes), and dissolved in 50 ml of a 10 mM ammonium buffer solution (pH 8.0). The solution is then passed through a column (5.5 x 80 cm) of Sephadex G-100 (3-dimensional cross-linked dextran powder made by Pharmacia Fine Chemicals, Co., Sweden) equilibrated in advance with 10 mM ammonium buffer solution (pH 8.0). One liter of 10 mM ammonium buffer solution is passed through the column and the eluate is obtained in fractions. From the fractions, 300 ml of a fraction having a high specific activity (protein content: 310 mg, specific activity: 3.2) is obtained and admixed with ammonium sulfate to 70% saturation to precipitate the enzyme. Then, the precipitates are collected by centrifugation (20,000 x G for 20 minutes) and dissolved in 20 ml of 10 mM ammonium buffer solution (pH 8.0). The resulting solution is dialyzed for 24 hours against 5 i of 10 mM ammonium buffer solution (pH 8.0), using a cellophane tube as a dialysis membrane, while twice exchanging the dialysis solution. After the dialysis, the resulting enzyme solution is passed through a column (5.5 x 20 cm) of hydroxyapatite equilibrated in advance with 10 mM ammonium buffer solution (pH 8.0). An additional 250 ml of the same buffer is passed through the column, and the eluate is obtained in fractions. Fractions having a specific activity higher than 20 are collected and freeze-dried, whereby 10.2 mg powder of purified enzyme preparate of glycerol oxidase (specific activity: 30.2) is obtained. The purified enzyme has a specific activity about 610 times as high as that of the cell extract. The yield is 19% in terms of activity.
Example 2
0025In this example, the same procedures as described in Example 1 are repeated except that Neurospora crassa KY-462 (NRRL 11106, FERM-P No. 3960) is used, whereby 1.1 mg of a purified enzyme preparate of glycerol oxidase (specific activity: 14.1) is obtained in a 10.5% yield in terms of activity.
0026Practice of certain specific embodiments of the invention are illustrated by the following representative examples wherein the enzymes used are as follows: <ul id="ul0001" list-style="none"><li>Lipase and a-chymotrypsin (protease) : products of Sei Kagaku Kogyo Co., Ltd. Japan.</li><li>G O D : The product obtained in Examples 1 or 2.</li><li>P O D : Product of Washington Co., U.S.A.</li><li>liquor of L P L : Product obtained from the culture / Rhizopus japonicus FERM p-3651.</li></ul>
Example 3
0027In this example, Reagent 1 is prepared by dissolving the following components in 0.1M TES - buffer solution (pH 8.0) to make up 25 ml of an enzyme solution. <tables id="tabl0001" num="0001"><img file="EP0010296A1_D0002.tif" /></tables>Then, 2.5 ml of the enzyme solution is poured into 10 ml - vials and is freeze-dried.
0028Reagent 2 is prepared by dissolving 500 IU of GOD and 1500 IU of POD in 0.1M TES-buffer solution (pH 8.0) to make up 25 ml of an enzyme solution. Then 2.5 ml of the enzyme solution is poured into 10 ml - vials and is freeze-dried.
0029A coloring solution is prepared by dissolving 300 mg of phenol and 300 mg of Triton X 100 in 0.1M TES-buffer solution (pH 8.0) to make up 25 ml of coloring solution.
0030A standard solution is also prepared by dissolving 26 mg of glycerol in 0.1M TES buffer solution (pH 8.0) to make up 100 ml of standard solution. The solution thus obtained contains 250 mg/dl of triolein. Unless otherwise indicated, the same standard is used in the following examples.
0031To carry out determination of triglyceride in a serum sample, the contents of a vial of Reagent-1 and a vial of Reagent-2 are dissolved in 30 ml of coloring solution to make up a test solution. Then 0.02 ml of serum is added to 3 ml of test solution and the mixture is incubated at 37°C for ten minutes. The absorption of the reaction solution at 505 nm is then measured. A calibration curve is prepared using the standard solution. Five samples of serum are tested according to the foregoing method and the results are shown below (table I). <tables id="tabl0002" num="0002"><img file="EP0010296A1_D0003.tif" /></tables>
Example 4
0032In this example, the components set forth below are dissolved in 25 ml of 0.1M TES-buffer solution (pH 6.8) to make up an enzyme reagent. <tables id="tabl0003" num="0003"><img file="EP0010296A1_D0004.tif" /></tables>After filtering, the solution is poured into 10 vials and freeze-dried.
0033To prepare a coloring solution, 350 mg of dimethylaniline is dissolved in 5 ml of water.
0034To prepare a buffer solution, 0.3 ml of Triton X 100 is dissolved in 0.1M <sub>T</sub>ES-buffer solution (pH 6.8) to make up 300 ml of solution.
0035To carry out determination of triglyceride in a serum sample, a vial of the enzyme reagent is dissolved in 30 ml of the buffer solution and 0.5 ml of coloring selution is added to the resultant solution to make up a test solution. Then, 0.02 ml of serum is added to 3 ml of test solution and incubated at 37°C for 10 minutes. Then, the absorption of the reaction solution at 550 nm is measured.
0036Five samples of serum is tested for the determination of triglyceride according to the foregoing method. The results are shown below (table II) . <tables id="tabl0004" num="0004"><img file="EP0010296A1_D0005.tif" /></tables>
Example 5
0037In this example, an enzyme reagent is prepared by dissolving 50 IU of GOD and 50 mg of lactose in 10 ml of water and the solution is poured into 10 vials and freeze-dried.
0038A solution for hydrolysis is prepared by dissolving 5.6 g of potassium hydroxide in 100 ml of absolute ethanol.
0039A 0.1M ammonium buffer solution is prepared by mixing 96 ml of 0.1M ammonium chloride and 3 ml of 0.1N aqueous ammonia.
0040For the determination of triglyceride in a serum sample, 0.02 ml of serum is poured into a test tube and 0.1 ml of solution for hydrolysis is added thereto. The mixture is subjected to hydrolysis at 75°C for <sub>1</sub>0 minutes. Then, 0.1 ml of 1N hydrochloride and 3 ml of 0.1M ammonium buffer solution are added thereto and the mixture is heated at 37°C for 10 minutes. An enzymatic electrode (Beckmann 160C, Beckmann Co.) is equipped to the test tube. A vial of enzyme reagent is-dissolved in 1 ml buffer solution and the enzyme solution is added to the test tube through a 0.1 ml microsyringe.
0041The change of oxygen uptake is then measured. A calibration curve is separately prepared using'the standard solution.
0042Five samples of serum are tested in the foregoing manner and the results are shown below (table III). <tables id="tabl0005" num="0005"><img file="EP0010296A1_D0006.tif" /></tables>
Example 6
0043In this example, an enzyme reagent is prepared by mixing the following components and pouring the mixture into five vials. <tables id="tabl0006" num="0006"><img file="EP0010296A1_D0007.tif" /></tables>
0044Then 300 mg of phenol and 300 mg of Triton X 100 are dissolved in 0.1M ammonium buffer solution (pH 8.0) to make up 100 ml of coloring reagent.
0045To carry out determination of triglyceride in serum sample, a vial of enzyme reagent is dissolved in a mixture of 20 ml of coloring reagent and 40 ml of water to make up a test solution. Then 20 µl samples of serum is added to 3 ml of the test solution and the reaction is carried out at 37°C for 5 minutes, after which the absorption at 505 nm is measured. The results for five samples are shown below (table IV). <tables id="tabl0007" num="0007"><img file="EP0010296A1_D0008.tif" /></tables>
Example 7
0046In this example, the following components are dissolved in 20 ml of water to make up an enzyme reagent. <tables id="tabl0008" num="0008"><img file="EP0010296A1_D0009.tif" /></tables>Then-5 ml of the solution is pipetted into vials and freeze-dried.
0047To carry out determination of triglyceride in a sample, a vial of the enzyme reagent is dissolved in 75 ml of the same coloring reagent solution as in Example 6 to make up a test solution. Then 0.02 ml of serum is added to 3 ml of test solution and is incubated at 37°C for 10 minutes after which absorption at 505 nm is measured.
004816 samples of serum are tested and the results are shown below. For comparison, the same serum samples are tested according to the known acetylacetone method, and the results are also set forth below (table V). <tables id="tabl0009" num="0009"><img file="EP0010296A1_D0010.tif" /></tables>
Example 8
0049In this example, the same procedures as described cholesterol in Example 7 are repeated except that 60,000 IU of / esterase (product obtained from the culture liquor of Pseudomonas fluorescens ATCC 31156) having lipoprotein lipase activity is used instead of LPL. Five samples of serum (sample Nos. 1, 3, 5, 7 and 9) and standard solution are tested according to the foregoing method. The amounts (mg/dl) of triglyceride are 145, 197, 250, 278, 288 and 250, respectively.
10 sheets
Sheet 1 Sheet 2 Sheet 3 Sheet 4 Sheet 5 Sheet 6 Sheet 7 Sheet 8 Sheet 9 Sheet 10
Every citation, both ways
| Document | Relation | Office | Cited during |
|---|---|---|---|
| US7727572B2 | Cited by | United States of America | Applicant |
| US8178090B2 | Cited by | United States of America | Applicant |
| US7931924B2 | Cited by | United States of America | Applicant |
| US7727572B2 | Cited by | United States of America | Applicant |
| EP0080304A1 | Cited by | European Patent Office (EPO) | Search report |
| US6406723B1 | Cited by | United States of America | Applicant |
| EP0080304A1 | Cited by | European Patent Office (EPO) | Search report |
| EP0019253A1 | Cited by | European Patent Office (EPO) | Search report |
| EP0033540A2 | Cited by | European Patent Office (EPO) | Search report |
| EP0033540A3 | Cited by | European Patent Office (EPO) | Search report |
| US6852346B2 | Cited by | United States of America | Applicant |
| US7745599B1 | Cited by | United States of America | Applicant |
| US8460723B2 | Cited by | United States of America | Applicant |
| US6726942B2 | Cited by | United States of America | Applicant |
| US6936289B2 | Cited by | United States of America | Applicant |
| US7544795B2 | Cited by | United States of America | Applicant |
| EP0048347A1 | Cited by | European Patent Office (EPO) | Search report |
| US6936289B2 | Cited by | United States of America | Applicant |
| US6924366B2 | Cited by | United States of America | Applicant |
| US8338153B2 | Cited by | United States of America | Applicant |
| WO9844804A1 | Cited by | World Intellectual Property Organization (WIPO) | International search |
| US7544795B2 | Cited by | United States of America | Applicant |
| US6924366B2 | Cited by | United States of America | Applicant |
| US8338153B2 | Cited by | United States of America | Applicant |
| EP0048347A1 | Cited by | European Patent Office (EPO) | Search report |
| US7745599B1 | Cited by | United States of America | Applicant |
| FR2387992A1 | Cites | France | Search report |
| DE2459087B2 | Cites | Germany | Search report |
| US4038146A | Cites | United States of America | Search report |
| RESEARCH DISCLOSURE, No. 161, September 1977, pages 94-98 Vant. Hants, G.B. "Integral Element for the detection of glycerol or triglycerides" * Pages 94,95; page 96, column 1 * | Non-patent | – | Search report |
4 priority claims, no other members on record
Priority claims4
| Document | Office | Kind | Date |
|---|---|---|---|
| 12732878 | Japan | A | |
| 12732878 | Japan | – | |
| JP19780127328 | – | – | – |
| 12732878 | – | – | – |
19 legal events, as 2 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| No opposition filed within time limitOppositionORIGINAL CODE: 0009261PLBE | PLBE | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA | STAA | EP | |
| Notification of lapseLapsedST | ST | FR | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Gb: european patent ceased through non-payment of renewal feeCeasedGBPC | GBPC | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| It: last paid annual feeITTA | ITTA | EP | |
| Corresponds to:REF | REF | EP | |
| Designated contracting statesAK | AK | EP | |
| (expected) grantORIGINAL CODE: 0009210GRAA | GRAA | EP | |
| It: translation for a ep patent filedITF | ITF | EP | |
| It: translation for a ep patent filedITF | ITF | EP | |
| Request for examination filed17P | 17P | EP | |
| Designated contracting statesAK | AK | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication
- 0010296
- Publication, DOCDB
- 0010296
- Publication, EPODOC
- EP0010296
- Application
- 79104011
- Application, DOCDB
- 79104011
- Application, EPODOC
- EP19790104011
Titles6
- German
- Reagenzzusammensetzung zur Bestimmung von Triglyceriden und deren Verwendung.
- English
- Test composition for the determination of triglycerides and its use.
- French
- Composition d'essai pour la détermination des triglycérides et son application.
- German
- Reagenzzusammensetzung zur Bestimmung von Triglyceriden und deren Verwendung
- English
- Test composition for the determination of triglycerides and its use
- French
- Composition d'essai pour la détermination des triglycérides et son application
Classification
- CPC, 2
- C12Q1/61
- C12Q1/26
- IPC, 4
- G01N33 92
- C12Q1 26
- C12Q1 28
- C12Q1 61
Designated states1
- Contracting states, 1
- Italy